BridgeBio Oncology Therapeutics, Inc. (BBOT) is a clinical-stage biotechnology company developing orally bioavailable small molecule inhibitors targeting RAS and PI3K oncogenes. Its pipeline includes BBO-8520 (dual KRAS G12C ON/OFF inhibitor), BBO-11818 (pan-KRAS ON/OFF inhibitor), and BBO-10203 (RAS:PI3K Breaker). These candidates are being evaluated in Phase 1 trials for NSCLC, KRAS mutant solid tumors, HER2+ breast cancer, HR+/HER2- breast cancer, and KRAS mutant colorectal cancer.
expected 2026-11-10
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-03-05 | 2025-12-31 | 0001193125-26-094112 | EDGAR | 111K words |
| 2025-03-11 | 2024-12-31 | 0001213900-25-022387 | EDGAR | 73K words |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-08-11 | 2026-06-30 | 0001193125-26-344661 | EDGAR | 79K words |
| 2025-11-12 | 2025-09-30 | 0001193125-25-277834 | EDGAR | 78K words |
| 2025-08-01 | 2025-06-30 | 0001213900-25-070659 | EDGAR | 22K words |
| 2025-05-15 | 2025-03-31 | 0001213900-25-044424 | EDGAR | 21K words |
| 2024-11-14 | 2024-09-30 | 0001213900-24-098483 | EDGAR | 15K words |
| 2024-08-14 | 2024-06-30 | 0001213900-24-068630 | EDGAR | 15K words |
| 2024-05-15 | 2024-03-31 | 0001213900-24-043582 | EDGAR | 14K words |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-09-08 | 0001193125-26-385225 | EDGAR | 4K words |
| 2026-08-11 | 0001193125-26-344608 | EDGAR | 2K words |
| 2026-03-26 | 0001193125-26-126493 | EDGAR | 1K words |
| 2026-03-05 | 0001193125-26-093997 | EDGAR | 3K words |
| 2026-01-07 | 0001193125-26-005425 | EDGAR | 2K words |
| 2025-11-12 | 0001193125-25-277601 | EDGAR | 2K words |
| 2025-08-13 | 0001213900-25-075190 | EDGAR | 14K words |
| 2025-08-06 | 0001213900-25-072312 | EDGAR | 1K words |
| 2025-08-04 | 0001213900-25-071392 | EDGAR | 3K words |
| 2025-07-11 | 0001213900-25-062955 | EDGAR | 2K words |
28 total filings indexed. 9 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0001869105 |
| Ticker | BBOT |
| Exchange | Nasdaq |
| SIC | 2834: Pharmaceutical Preparations |
| Incorporated | DE |
| Website | https://www.bridgebio.com |
| Listed | 2025-08-12 |
This is a static snapshot. For live, structured JSON with cryptographic provenance chain:
MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp
Try it — paste this into your AI:
Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.
claude mcp add origin --transport http https://origin.rootz.global/mcpGET https://origin.rootz.global/api/company/BBOT (~200 tokens, structured JSON with cryptographic provenance)